Q&A With Sullivan & Cromwell's Keith Pagnani

Law360, New York (June 26, 2012, 1:53 PM EDT) -- Keith Pagnani is a partner in Sullivan & Cromwell LLP's New York office. He is co-head of the firm’s health care and life sciences group and is a member of the firm’s managing partners billing policy and diversity committees. He advises domestic and international clients in M&A transactions across various sectors, including pharmaceuticals, biotech and life sciences, medical devices, medical information systems and technologies, health providers, insurance and managed care. Recent representations include Alcon-Novartis ($50 billion), Valeant-Cephalon bid ($5.7 billion), ZOLL-Asahi Kasei ($2.21 billion), Medica HealthCare-United...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.